O
BMY icon

OppenheimerFunds’s Bristol-Myers Squibb BMY Stock Holding History

OppenheimerFunds’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$46.4M Sell
972,307
-655,354
-40% -$32.6M 0.06% 327
2018
Q4 		$84.6M Buy
1,627,661
+150,403
+10% +$8.08M 0.12% 166
2018
Q3 		$91.7M Buy
1,477,258
+469,303
+47% +$27.9M 0.11% 212
2018
Q2 		$55.8M Sell
1,007,955
-77,191
-7% -$4.17M 0.07% 310
2018
Q1 		$68.6M Sell
1,085,146
-678,554
-38% -$43.7M 0.09% 255
2017
Q4 		$108M Sell
1,763,700
-397,466
-18% -$24.9M 0.13% 177
2017
Q3 		$138M Buy
2,161,166
+559,947
+35% +$32.7M 0.17% 144
2017
Q2 		$89.2M Buy
1,601,219
+449,608
+39% +$24.5M 0.11% 208
2017
Q1 		$62.6M Buy
1,151,611
+952,385
+478% +$52.2M 0.08% 263
2016
Q4 		$11.6M Sell
199,226
-512,640
-72% -$28M 0.01% 727
2016
Q3 		$38.4M Sell
711,866
-6,206,832
-90% -$399M 0.05% 397
2016
Q2 		$509M Buy
6,918,698
+244,139
+4% +$17.3M 0.67% 26
2016
Q1 		$426M Buy
6,674,559
+1,852,108
+38% +$117M 0.57% 41
2015
Q4 		$332M Buy
4,822,451
+677,602
+16% +$44.8M 0.42% 60
2015
Q3 		$245M Buy
4,144,849
+423,472
+11% +$26.9M 0.33% 83
2015
Q2 		$248M Sell
3,721,377
-2,197,096
-37% -$145M 0.28% 95
2015
Q1 		$382M Sell
5,918,473
-691,805
-10% -$43.3M 0.43% 55
2014
Q4 		$390M Buy
6,610,278
+3,418,128
+107% +$193M 0.43% 52
2014
Q3 		$163M Sell
3,192,150
-1,455,380
-31% -$72.7M 0.18% 151
2014
Q2 		$225M Sell
4,647,530
-74,580
-2% -$3.68M 0.25% 107
2014
Q1 		$245M Sell
4,722,110
-866,145
-15% -$46.1M 0.29% 91
2013
Q4 		$297M Sell
5,588,255
-5,210,315
-48% -$265M 0.36% 66
2013
Q3 		$500M Buy
10,798,570
+5,428,177
+101% +$238M 0.33% 82
2013
Q2 		$240M Buy
+5,370,393
New +$233M 0.35% 75

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

OppenheimerFunds's BMY Position: Q1 2019 in Review

OppenheimerFunds reduced its Bristol-Myers Squibb (BMY) stake by 40% in Q1 2019, selling an estimated $32.6M and leaving 972,307 shares worth $46.4M. The position accounts for 0.06% of the portfolio, ranked #327.

OppenheimerFunds first reported a position in BMY in Q2 2013 and has held it in 24 quarters since. The position peaked at $509M in Q2 2016. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • OppenheimerFunds held 972,307 shares of Bristol-Myers Squibb worth $46.4M as of Q1 2019.
  • OppenheimerFunds sold 655,354 Bristol-Myers Squibb shares in Q1 2019, an estimated $32.6M.
  • Bristol-Myers Squibb made up 0.06% of OppenheimerFunds's portfolio in Q1 2019, its #327 holding.
  • OppenheimerFunds first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Bristol-Myers Squibb position peaked at $509M in Q2 2016.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.